Keyword Analysis & Research: biogen news
Keyword Research: People who searched biogen news also searched
Search Results related to biogen news on Search Engine
-
News | Biogen
https://investors.biogen.com/news/news-releases
Web ResultMay 7, 2018 · Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression. January 29, 2023. News Release.
DA: 36 PA: 6 MOZ Rank: 61
-
Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, …
https://finance.yahoo.com/news/biogen-qalsody-tofersen-first-therapy-120000872.html
Web ResultFeb 23, 2024 · CAMBRIDGE, Mass., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a...
DA: 91 PA: 46 MOZ Rank: 85
-
Biogen to Realign Resources for Alzheimer's Disease Franchise
https://investors.biogen.com/news-releases/news-release-details/biogen-realign-resources-alzheimers-disease-franchise
Web ResultJan 31, 2024 · CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced plans to reprioritize its resources in Alzheimer’s disease (AD), a strategic therapeutic area expected …
DA: 57 PA: 99 MOZ Rank: 81
-
FDA Approves Biogen’s Drug for Rare Form of ALS - The New York Times
https://www.nytimes.com/2023/04/25/business/biogen-fda-als-drug.html
Web ResultBy Rebecca Robbins. April 25, 2023. The Food and Drug Administration on Tuesday authorized the first drug for a rare genetic form of the neurological disorder A.L.S., despite uncertainty about the...
DA: 77 PA: 88 MOZ Rank: 27
-
FDA Approves LEQEMBI™ (lecanemab-irmb) Under the Accelerated ... - Biogen
https://investors.biogen.com/news-releases/news-release-details/fda-approves-leqembitm-lecanemab-irmb-under-accelerated-approval
Web ResultINDICATION. LEQEMBI is indicated for the treatment of Alzheimer's disease. Treatment with LEQEMBI should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials.
DA: 89 PA: 60 MOZ Rank: 52
-
Alzheimer’s Drug Slows Cognitive Decline in Key Study
https://www.nytimes.com/2022/09/27/business/alzheimers-drug-biogen-lecanemab.html
Web ResultSep 27, 2022 · Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing. 70. Lecanemab reduced cognitive decline by 27 percent in a clinical trial...
DA: 27 PA: 16 MOZ Rank: 17
-
Biogen CEO bets on Alzheimer's drug, pipeline to return to growth
https://www.reuters.com/business/healthcare-pharmaceuticals/biogen-earnings-beat-estimates-boost-muscle-disorder-drug-2023-02-15/
Web ResultFeb 15 (Reuters) - Biogen Inc (BIIB.O) Chief Executive Officer Christopher Viehbacher said on Wednesday he is banking on high-profile launches of Alzheimer's disease treatment Leqembi and...
DA: 21 PA: 36 MOZ Rank: 61
-
Biogen to Realign Resources for Alzheimer's Disease Franchise
https://finance.yahoo.com/news/biogen-realign-resources-alzheimers-disease-123000872.html
Web ResultJan 31, 2024 · CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced plans to reprioritize its resources in Alzheimer’s disease (AD), a strategic therapeutic area...
DA: 89 PA: 73 MOZ Rank: 59
-
New Alzheimer’s drug Leqembi is granted full FDA approval - NBC News
https://www.nbcnews.com/health/health-news/leqembi-alzheimers-drug-fda-approval-eisai-biogen-rcna92377
Web ResultJul 6, 2023 · Leqembi, from Japanese drugmaker Eisai and U.S.-based drugmaker Biogen, targets a type of protein in the brain called beta-amyloid, long thought by scientists to be one of the underlying causes...
DA: 8 PA: 10 MOZ Rank: 47
-
Alzheimer's disease: FDA approves Biogen, Eisai treatment lecanemab - CNBC
https://www.cnbc.com/2023/01/06/alzheimers-disease-fda-decision-on-biogen-eisai-treatment-lecanemab.html
Web ResultJan 6, 2023 · FDA approves Biogen’s Alzheimer’s drug. The FDA can accelerate approval of a drug to quickly bring it to market if it’s expected to help patients suffering from serious conditions more than what...
DA: 13 PA: 54 MOZ Rank: 92